China SXT Pharmaceuticals, Inc. (SXTC)

China SXT Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is April - March.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2024	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Cash & Equivalents	12.07	12.07	17.37	15.52	13.33	7.29
Cash & Short-Term Investments	12.07	12.07	17.37	15.52	13.33	7.29
Cash Growth	-30.50%	-30.50%	11.88%	16.44%	82.97%	-20.19%
Accounts Receivable	1.31	1.31	1.34	3.37	4.51	3.84
Other Receivables	0.03	0.03	0.23	0.66	0.65	4.37
Receivables	1.35	1.35	1.58	5.53	6.66	9.7
Inventory	0.81	0.81	0.58	1.07	1.38	1.05
Restricted Cash	0.01	0.01	-	0.05	0.03	-
Other Current Assets	-	-	-	0.29	1.83	1.6
Total Current Assets	14.23	14.23	19.52	22.45	23.23	19.64
Property, Plant & Equipment	0.56	0.56	1.27	1.59	1.79	1.9
Other Intangible Assets	0.02	0.02	0.03	0.04	0.05	0.05
Long-Term Deferred Tax Assets	-	-	-	-	0.32	0.11
Other Long-Term Assets	8.31	8.31	8.74	9.46	9.16	-
Total Assets	23.13	23.13	29.55	33.55	34.55	21.7
Accounts Payable	1.28	1.28	1.38	1.48	1.46	1.94
Accrued Expenses	1.59	1.59	1.74	2.01	1.51	0.81
Short-Term Debt	3.32	3.32	8.53	10.73	12.15	-
Current Portion of Long-Term Debt	0.02	0.02	0.01	0.01	0.04	6.69
Current Portion of Leases	0.06	0.06	0.06	-	-	-
Current Income Taxes Payable	1.05	1.05	1.1	1.17	1.16	0.99
Current Unearned Revenue	0.19	0.19	0.17	-	-	-
Other Current Liabilities	1.39	1.39	1.52	1.72	2.26	1.84
Total Current Liabilities	8.9	8.9	14.5	17.12	18.58	12.26
Long-Term Debt	0.12	0.12	0.12	-	0.01	0.04
Long-Term Leases	0.18	0.18	0.25	-	-	-
Total Liabilities	9.2	9.2	14.86	17.12	18.59	12.3
Common Stock	4.35	4.35	0.91	0.16	0.06	0.03
Additional Paid-In Capital	35.32	35.32	35.59	30.99	25.32	17.16
Retained Earnings	-24.71	-24.71	-21.61	-15.69	-9.95	-7.2
Comprehensive Income & Other	-1.03	-1.03	-0.2	0.96	0.53	-0.59
Shareholders' Equity	13.93	13.93	14.69	16.42	15.96	9.4
Total Liabilities & Equity	23.13	23.13	29.55	33.55	34.55	21.7
Total Debt	3.7	3.7	8.96	10.74	12.19	6.72
Net Cash (Debt)	8.38	8.38	8.41	4.78	1.14	0.56
Net Cash Growth	-0.39%	-0.39%	75.82%	319.07%	102.64%	-91.13%
Net Cash Per Share	9.66	9.66	31.49	114.98	39.65	45.55
Filing Date Shares Outstanding	3.48	3.48	0.57	0.11	0.03	0.03
Total Common Shares Outstanding	2.22	2.22	0.46	0.08	0.03	0.02
Working Capital	5.33	5.33	5.02	5.33	4.65	7.37
Book Value Per Share	6.28	6.28	32.12	202.14	514.05	542.36
Tangible Book Value	13.91	13.91	14.66	16.39	15.92	9.35
Tangible Book Value Per Share	6.27	6.27	32.06	201.66	512.58	539.48
Machinery	1.19	1.19	1.24	1.27	1.19	1.04
Construction In Progress	-	-	-	0.36	0.36	0.33
Leasehold Improvements	1.56	1.56	1.64	1.78	1.7	1.56

Source: S&P Capital IQ. Standard template. Financial Sources.